Endobronchial and Endoscopic Ultrasound-Guided Transvascular Biopsy of Mediastinal, Hilar, and Lung Lesions

Kazakov, Jordan; Hegde, Poornima; Tahiri, Mehdi; Thiffault, Vicky; Ferraro, Pasquale; Liberman, Moïshe

doi:10.1016/j.athoracsur.2016.08.111

Cited by 29 publications

(34 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2012, another series of EUS guided para‐vascular station 6 lymph node sampling was described, with 12 patients undergoing successful sampling with no complications . Kazakov et al recently described their experience with trans‐aortic sampling (19/33 patients, no complications), which also appear to be solely EUS‐guided . All these reports are EUS‐guided trans‐aortic or para‐vascular station 6 punctures, with EBUS guided trans‐aortic puncture described only in reports by Pattabhiraman et al (1 case) and Mehta et al (2 cases) with no complications .…”

Section: Discussionmentioning

confidence: 99%

“…21 Kazakov et al recently described their experience with trans-aortic sampling (19/33 patients, no complications), which also appear to be solely EUS-guided. 22 All these reports are EUS-guided transaortic or para-vascular station 6 punctures, with EBUS guided trans-aortic puncture described only in reports by Pattabhiraman et al (1 case) and Mehta et al (2 cases) with no complications. 23,24 In short, besides these 3 cases, we did not find any literature on EBUS guided trans-aortic sampling.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Defining expanded areas in EBUS sampling: EBUS guided trans‐ and intra‐pulmonary artery needle aspiration, with review of transvascular EBUS

Mehta

Biraris

Pattabhiraman³

et al. 2018

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Defining expanded areas in EBUS sampling: EBUS guided trans‐ and intra‐pulmonary artery needle aspiration, with review of transvascular EBUS

Mehta

Biraris

Pattabhiraman³

et al. 2018

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

“…Boujaoude et al described two cases of right hilar tumor biopsied with EBUS-TBNA through the pulmonary artery: the diagnosis was reached in both cases, and no complications were reported [15]. Kazakow et al described 15 consecutive patients who underwent EBUSand EUS-guided trans-vascular biopsy in an outpatient setting [16]. Eight biopsies were done through the pulmonary artery and in seven through the aorta.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic yield and safety of EUS-FNA biopsy in sub-aortic and para-aortic lymph node stations with the trans-aortic approach: a case series and literature review

Ravaglia

Colella²,

Tomassetti

et al. 2018

European Clinical Respiratory Journal

View full text Add to dashboard Cite

Background: Sub-aortic (station 5) and para-aortic (station 6) lymph nodes are not easily accessible due to the interposition of the aorta and the left pulmonary artery. Taking a biopsy from those stations could be of value when there are no other mediastinal lymph node stations or when biopsy in other sites failed to reach a diagnosis. Surgery is the gold standard technique in the evaluation of those stations; endoscopic ultrasound-fine needle aspiration (EUS-FNA) has been proposed as a minimally invasive technique through the trans-aortic approach, with an acceptable diagnostic yield and safety profile. Objective: To evaluate diagnostic accuracy and safety of the trans-aortic EUS-FNA in lymph node stations 5 and 6. Methods: We reviewed all patients who underwent trans-aortic EUS-FNA from 2010 to 2017, for mediastinal lymph node enlargement or positron emission tomography/computed tomography (PET/CT) positivity (integrated 2-deoxy-2-fluoro-D-glucose). Demographic characteristics, lesion site and size, needle, final diagnosis, and complications were collected. Results: A total of 11 patients were included, 5 males, mean age 59 years. Samples were inadequate in two cases, a diagnosis of lung cancer was reached in four patients (two adenocarcinoma and two squamous cell carcinoma) and five cases were negative for malignancy (one confirmed by surgery, two were found to be cancer at percutaneous lung biopsy and transbronchial biopsy, one patient received a diagnosis of Langerhans cell histiocytosis by transbronchial lung cryobiopsy, and one patient was lost at follow-up). The sensitivity for malignancy was 57%, and the overall diagnostic accuracy was 45%. No complications occurred. Conclusions: Trans-aortic EUS-FNA could be proposed as a valuable and safe approach for taking biopsy from mediastinal lymph node stations 5 and 6.

show abstract

“…On average, the addition of transoesophageal endoscopic ultrasound (EUS) to EBUS increased sensitivity by 0.12 (95% confidence interval EBUS can also obtain tissue samples from the left adrenal glands with a transgastric approach 16 , as well as with a transvascular approach, through the pulmonary artery and aorta 17 , with no complications.…”

Section: Stagingmentioning

confidence: 99%

Lung Cancer Management: where are we in 2017?

Scagliotti¹,

Bironzo²,

Rosell³

2021

BRN

View full text Add to dashboard Cite

Endobronchial and Endoscopic Ultrasound-Guided Transvascular Biopsy of Mediastinal, Hilar, and Lung Lesions

Abstract: In this series, EBUS- and EUS-guided transvascular approach for biopsy of mediastinal, hilar, and lung lesions was not associated with significant complications. However, careful selection of potential candidates and close periprocedural observation are mandatory.

Cited by 29 publications

References 25 publications

Defining expanded areas in EBUS sampling: EBUS guided trans‐ and intra‐pulmonary artery needle aspiration, with review of transvascular EBUS

Defining expanded areas in EBUS sampling: EBUS guided trans‐ and intra‐pulmonary artery needle aspiration, with review of transvascular EBUS

Diagnostic yield and safety of EUS-FNA biopsy in sub-aortic and para-aortic lymph node stations with the trans-aortic approach: a case series and literature review

Lung Cancer Management: where are we in 2017?

Contact Info

Product

Resources

About